The SphK blocker SKI-II has shown promising effects in attenuating memory impairments and stimulating hippocampal synaptic plasticity, autophagy, and cell surveillance-related pathways in the valproic acid-induced ASD rat model [259]. Here, SPHK1 is linked to memory impairment.